The "European Union: CBD and Cannabis Regulation" report has been added to ResearchAndMarkets.com's offering.
A comprehensive report delves into the intricate regulatory landscape within the European Union concerning cannabis, hemp, CBD, and various cannabinoids. This analysis extends across all policy domains to offer a holistic perspective.
Within the European Union, hemp is gaining recognition as a pivotal crop, with growing emphasis on its role in economic and environmental progress. Notably, the Kanavape case has set the stage for the potential legalization of CBD throughout the EU. However, the extent to which member states adhere to this judgment remains inconsistent.
While CBD undergoes a transformation within EU regulations, there exists no uniform, EU-wide regulatory framework for medicinal cannabis at present. As the region grapples with evolving attitudes and policies, the report provides invaluable insights into this complex regulatory terrain.
Key Topics Covered:
- Executive summary
- Hemp plant
- Extracts and synthetics
- Finished products containing CBD and extracts
- Import and export requirements
- Minor cannabinoids
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
For more information about this report visit https://www.researchandmarkets.com/r/kx4ueu
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900